These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32360116)

  • 21. Cardiovascular considerations in middle-aged athletes at risk for coronary artery disease.
    Reamy BV; Ledford CC
    Curr Sports Med Rep; 2013; 12(2):70-6. PubMed ID: 23478556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Stent thrombosis in patients with myocardial infarction].
    Rogan SV; Arablinskiĭ AV; Solov'ev OP
    Kardiologiia; 2003; 43(2):77-81. PubMed ID: 12891277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study.
    Meijer A; Verheugt FW; Werter CJ; Lie KI; van der Pol JM; van Eenige MJ
    Circulation; 1993 May; 87(5):1524-30. PubMed ID: 8491007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sudden cardiac death in athletes].
    Parikka H
    Duodecim; 2013; 129(15):1536-43. PubMed ID: 24163971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) trial.
    Yusuf S
    Am J Cardiol; 1999 Sep; 84(5A):20M-25M. PubMed ID: 10505539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Stents in interventional cardiology].
    Grinius V; Navickas R; Unikas R
    Medicina (Kaunas); 2007; 43(3):183-9. PubMed ID: 17413246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antithrombotic prophylaxis in patients with ventricular dysfunction: critical review of the literature and new perspectives].
    Scardi S; Mazzone C
    Ital Heart J Suppl; 2003 Mar; 4(3):201-9. PubMed ID: 12784754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sudden cardiac death prevention in athletes. Electrocardiogram interpretation: the Seattle criteria].
    Mélon P
    Rev Med Liege; 2014 Dec; 69(12):668-70. PubMed ID: 25796784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cilostazol for prevention of thrombosis and restenosis after intracoronary stenting.
    El-Beyrouty C; Spinler SA
    Ann Pharmacother; 2001 Sep; 35(9):1108-13. PubMed ID: 11573862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of combined history, physical examination, electrocardiogram, and limited echocardiogram in screening adolescent athletes for risk for sudden cardiac death.
    Anderson JB; Grenier M; Edwards NM; Madsen NL; Czosek RJ; Spar DS; Barnes A; Pratt J; King E; Knilans TK
    Am J Cardiol; 2014 Dec; 114(11):1763-7. PubMed ID: 25307198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enoxaparin in acute coronary syndromes: evidence for superiority over placebo or untreated control.
    Massel D; Cruickshank MK
    Am Heart J; 2002 May; 143(5):748-52. PubMed ID: 12040333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A guide to drug use during percutaneous coronary intervention.
    Choo JK; Young JJ; Kereiakes DJ
    Drugs; 2002; 62(18):2589-601. PubMed ID: 12465999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of intra-coronary thrombosis in the anaesthetised dog: the importance of thromboxane A2 and thrombin.
    White BP; Sullivan AT; Lumley P
    Thromb Haemost; 1994 Mar; 71(3):366-74. PubMed ID: 8029802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unusual cause of aborted sudden cardiac death in a teen athlete: homozygosity for the 4G allele of the plasminogen activase inhibitor type 1 gene.
    Phillips SB; Batlivala S; Knudson JD
    Cardiol Young; 2015 Oct; 25(7):1428-30. PubMed ID: 25498839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sudden cardiac death in athletes.
    Link MS; Mark Estes NA
    Prog Cardiovasc Dis; 2008; 51(1):44-57. PubMed ID: 18634917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pheidippides redux: reducing risk for acute cardiac events during marathon running.
    Siegel AJ
    Am J Med; 2012 Jul; 125(7):630-5. PubMed ID: 22608535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary thrombolysis, conjunctive heparin infusion, and the effect on systemic thrombin activity.
    Garabedian HD; Gold HK
    Circulation; 1992 Mar; 85(3):1205-7. PubMed ID: 1537116
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sudden cardiac death in athletes and its prevention].
    Tönnis T; Tack C; Kuck KH
    Herz; 2015 May; 40(3):379-85. PubMed ID: 25963171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Pilot Study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation.
    Anand SS
    Am J Cardiol; 1999 Sep; 84(5A):13M-19M. PubMed ID: 10505538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.